← FDA Drug Approvals (Drugs@FDA)
CONJUGATED ESTROGENS
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2025-10-15
Drug application
- FDA Application #
ANDA214023- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CONJUGATED ESTROGENS
- Generic name
- ESTROGENS, CONJUGATED
- Active ingredients
- ESTROGENS, CONJUGATED
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NOVAST LABS
- Manufacturer
- Ingenus Pharmaceuticals, LLC
- First approval
- 2025-10-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown